MFDS — authorised 30 August 2005
- Marketing authorisation holder: IPSEN INC
- Status: likely_approved
🇰🇷 Increlex in South Korea
MFDS authorised Increlex on 30 August 2005
Marketing authorisation
Increlex in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Metabolic approved in South Korea
Frequently asked questions
Is Increlex approved in South Korea?
Yes. MFDS authorised it on 30 August 2005.
Who is the marketing authorisation holder for Increlex in South Korea?
IPSEN INC holds the South Korean marketing authorisation.